Macular Degeneration Research
Custom Search
Macular degeneration research involves many aspects of this disease including prevention, treatment, nutrition, and ways to better utilize the vision one does have. Information on macular degeneration clinical trials are available at the National Institues of Health website. It lists not only studies in the U.S. but internationally as well. Here is a sampling of some of the current studies.
Macular Degeneration Treatment BreakthroughThe COMPLETE study may prove to be a macular degeneration breakthrough. This study is looking at treating the actual cause of macular degeneration. Philip J. Rosenfeld, MD, PhD is a Professor of Ophthalmology at the Bascom Palmer Eye Institute in Miami, Florida.As the principle investigator for this clinical trial he has shed some light on AMD clinical trials and more specifically how this macular degeneration study looks at the factors that may cause this retinal disease. To read our exclusive interview with Dr. Rosenfeld click here:
Macular Degeneration Treatment Breakthrough AMD Clinical TrialsAMD clinical trials for wet macular degeneration treatment involve many different treatment options. There are studies looking at new combinations of existing treatment - such as anti-VEGF injections and photodynamic therapy. Other studies are looking at radiation therapy in conjunction with macular degeneration medication or injections. To see what's available click here: Wet Macular Degeneration Clinical TrialsEccentric Viewing or Preferred Retinal Location - December 2008
Macular degeneration research also involves the better use of the vision a person does have through using their peripheral vision.The December edition of the Journal of Restorative Neurology and Neuroscience reports that "Reorganization of visual processing is related to eccentric viewing in patients with macular degeneration." In other words when macular degeneration patients compensate for their loss of central vision by using their peripheral vision or what is called a Preferred Retinal Location (where there are healthy photoreceptor cells), the brain reorganizes as well. There seems to be a reorganization in the visual cortex. This knowledge may lead to the development of more effective rehabilitation programs or tools to enhance the of those with AMD. It may also suggest that earlier intervention of eccentric viewing rehabilitation for those with early stage AMD may help promote this cortical reorganization earlier. To read more about Eccentric Viewing click here: Eccentric Viewing Low Glycemic Carbs and AMDMacular Degeneration Research and Low Glycemic Carbs According to Allen Taylor, Ph.D. and a team of scientists from Tufts University there may be a correlation between eating food with a high glycemic index and and increased risk or progression of macular degeneration. The team analyzed dietary data from over 4,000 people who participated in the National Eye Institute's Age-Related Eye Disease Study (AREDS). Their conclusion found there to be a connection between eating foods with a high glycemic index and an increased risk of developing or worsening macular degeneration. Another study of 600 individuals by Dr. Taylor, an Australian study as well have all reported the same findings. Low glycemic carbs are part of a healthy macular degeneration diet and an anti-inflammatory diet. To learn what kinds of food have a high glycemic index and what foods have a low glycemic index click here: low glycemic carbs Low Vision Depression Prevention Trial"Age-related macular degeneration (AMD) is the leading cause of blindness in older persons in the U.S. and affects more than 10 million people. One third of patients with AMD become clinically depressed when they lose the ability to pursue valued activities. Because their depression is disabling and unlikely to be treated, preventing depression in AMD is a public health imperative as the population ages.We will recruit 200 subjects who have bilateral AMD and subthreshold depressive symptoms. Their bilateral vision loss and subthreshold depressive symptoms increase their risk to develop more severe depressive disorders and functional decline. We will randomize eligible subjects to collaborative Low Vision Rehabilitation (LVR) (optometrist and home-based OT) or enhanced LVR (optometrist and home-based Supportive Therapy). In this study, usual care LVR is enhanced with Supportive Therapy (ST), which is a standardized placebo psychological treatment that controls for attention." Eligibility Ages Eligible for Study: 65 Years and older Genders Eligible for Study: Both Inclusion Criteria: * Age at least 65 years old * Bilateral AMD * Subthreshold depressive symptoms * At least 1 vision goal that is important yet difficult to carry out Exclusion Criteria: * Uncontrolled glaucoma, diabetic retinopathy, corneal dystrophy, or cataracts for which surgery within 6 months is likely will be exclusionary conditions * Current diagnosis of depression * Cognitive impairment * Life-threatening illness or any other health conditions that interferes with study activities. * Patients who have received low vision rehabilitation or home-based OT in the preceding 12 months will be excluded. LocationsUnited States, PennsylvaniaThomas Jefferson UniversityPhiladelphia, Pennsylvania, United States, 19107 Sponsors and Collaborators Thomas Jefferson University Dartmouth-Hitchcock Medical Center Johns Hopkins University Macular Degeneration Studies Near YouIf you are interested in finding out if there are any macular degeneration studies near you clilck on this link and fill out the form and I can perform a search for you. Macular Degeneration Studies SearchGo from Macular Degeneration Research to Macular Degeneration
Would you like to be updated on: √ The latest Macular Degneration Research? 
√ Prevention of Macular Degeneration?√ Tips for Daily Living? √ Food Suggestions for a Macular Degeneration Diet? √ Ideas on Visual Aids to Maximize your Sight? If you said "yes" to any of the above, sign up for my monthly Macular Degeneration News.
|
